News
The ranibizumab ocular implant (Susvimo) reduces the need for frequent intravitreal anti-VEGF injections in patients with neovascular age-related macular degeneration or diabetic macular edema, and ...
Boyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, ...
The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...
The new offering, designed specifically for prefilled syringes used in various applications, complements its 1 mL ImProject ...
Sunir Garg, MD, discusses a challenge in ophthalmological procedures: patient discomfort during intravitreal injections ...
Purpose To evaluate the real-life safety profile of intravitreal dexamethasone implant injection for various retinal conditions. Methods Retrospective multicenter analysis of intravitreal ...
He was diagnosed as having stage 3A Coats’ disease in OS and treated with an intravitreal injection of ranibizumab and cryotherapy, without improvement. Thus, we de decided to treat him with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results